rPCR vs Virgin Plastics in Packaging: ASTM Data and Berry Global’s Super Clean Advantage
- Introduction: The performance question behind recycled plastics
- ASTM test data: How 50% rPET compares to virgin PET
- Super Clean process: Turning rPCR into FDA-grade input
- Commercial proof: Unilever Dove’s journey to 100% rPCR
- Addressing the controversy: Not all rPCR is equal
- From testing to design: Practical guidelines for engineering teams
- Policy, markets, and circular economy: Why momentum will continue
- Berry Global’s advantage: Full portfolio and vertical integration
- Bottom line: Evidence over assumptions
Introduction: The performance question behind recycled plastics
In packaging, few topics spark more debate than whether recycled plastics can match the performance and safety of virgin polymers. Berry Global, a U.S.-based leader in full-spectrum plastic packaging solutions (rigid + flexible + films + closures) with deep vertical integration from resin to finished goods, has spent the past decade turning this question into measurable evidence, commercial proof, and scale. The result: with the right process, rPCR recycled plastic can meet demanding food-contact and performance requirements while materially advancing a circular economy strategy.
This technical review focuses on side-by-side ASTM test data, the Super Clean process that elevates rPCR purity to FDA acceptance, and a five-year commercialization journey with Unilever’s Dove that reached 100% rPCR at global scale. We also address common controversies, acknowledge the limitations of low-quality rPCR, and outline practical design guidelines for brand engineering teams.
ASTM test data: How 50% rPET compares to virgin PET
To move beyond opinion, Berry Global commissioned an independent, ASTM-certified laboratory to evaluate 500ml carbonated beverage bottles made with 50% rPET and 50% virgin PET versus bottles made with 100% virgin PET. The test protocol followed ASTM D2463 (bottle performance) and included oxygen permeability (ASTM F1927) and FDA food-contact migration testing.
- Burst strength (ASTM D2463)
Berry 50% rPET: 14.2 bar average (SD 0.8), minimum 12.5 bar
100% virgin PET: 15.1 bar average (SD 0.6), minimum 13.8 bar
Interpretation: rPET blend measured ~6% lower than virgin, yet comfortably above typical commercial minimums (>10 bar). - Drop test (1.5m, filled, capped)
Berry 50% rPET: 96% intact (48/50), failures at base
100% virgin PET: 98% intact (49/50), failures at base
Interpretation: A 2% difference in intact rate, both meeting standard commercial acceptance (>95%). - Oxygen transmission (ASTM F1927)
Berry 50% rPET: 0.13 cc/bottle/day
100% virgin PET: 0.11 cc/bottle/day
Interpretation: rPET blend shows slightly higher transmission (+18%) yet remains within typical carbonated beverage targets (<0.15 cc/bottle/day). - FDA food-contact migration
Berry 50% rPET: total migration 3.2 ppm
100% virgin PET: total migration 2.8 ppm
Interpretation: Both results are far below the 10 ppm limit, confirming food-contact suitability.
These results (TEST-BERRY-001) show a consistent pattern: small, measurable differences versus virgin PET—generally under 10%—that remain within acceptable performance windows for mainstream beverage applications. At scale, this enables meaningful emissions reduction; for a scenario of 1 billion 500ml bottles, a 50% rPET formulation can cut CO₂ by approximately 28,750 tons (about 33% reduction) compared to an all-virgin baseline.
Super Clean process: Turning rPCR into FDA-grade input
If rPCR quality varies, process is the differentiator. Berry Global’s Super Clean methodology is designed to remove contaminants to levels accepted by the FDA for food-contact uses, achieving rPCR purity above 99.9% (FDA Letter of No Objection, LNO). The process integrates multiple advanced steps beyond conventional mechanical recycling:
- Source control and sorting: Predominantly post-consumer PET beverage bottles (PCR) augmented by post-industrial residues (PIR) with rigorous sorting to minimize mixed-polymer contamination.
- Deep cleaning: intensive washing sequences, including hot washing and label/adhesive removal, to strip residues and organics that can degrade performance or migrate.
- Super Clean refinement: elevated-temperature treatment (~220°C), vacuum degassing, and multi-stage decontamination to remove volatile and semi-volatile compounds to below FDA thresholds.
- Re-compounding and blending: controlled re-pelletization and blending ratios (e.g., 50:50 rPET:virgin) tuned to meet specific performance targets without overspecifying material.
In practical terms, Super Clean rPCR is engineered so that migration remains well below the 10 ppm limit and the mechanical and barrier properties stay within design envelopes for typical packaging applications. The proof is not merely in lab results—Berry’s rPCR has passed FDA scrutiny and has scaled into multi-hundred-million-unit packaging programs.
Commercial proof: Unilever Dove’s journey to 100% rPCR
Test data matters, but commercialization is the ultimate validation. In partnership with Unilever’s Dove brand, Berry Global guided a five-year progression from 25% rPCR to 100% rPCR HDPE bottles across markets worldwide (CASE-BERRY-001):
- Phase 1 (2019–2020): 25% rPCR in 400ml shampoo bottles (North America). Drop-test pass rate reached 98% (vs. 100% for virgin), and consumer panels reported 85% could not distinguish between rPCR and virgin bottles. A modest gray hue appeared but did not impact shelf presence; unit cost rose by about $0.02 per bottle (+15%), an acceptable environmental premium.
- Phase 2 (2021–2022): Increased to 50%, then 75% rPCR. Berry introduced multi-layer coextrusion to balance aesthetics and performance: an outer layer leveraging high-quality rPCR, an inner virgin layer for consistency, and an optional barrier layer to stabilize overall properties. As the rPCR share grew, Dove refined labeling to embrace an “eco” visual while maintaining brand equity.
- Phase 3 (2023–2024): 100% rPCR HDPE bottles scaled in Europe and then globally. Berry’s work with Ocean Bound Plastic sourcing (materials collected within 50km of coastlines in Indonesia and the Philippines) underwent Super Clean treatment to remove salts, sand, and contaminants, achieving purity >99.5% for this stream. By 2024, ~80% of Dove’s global volume—about 800 million bottles—transitioned to 100% rPCR, with a cumulative five-year rPCR usage of 120,000 tons and an estimated 276,000 tons of CO₂ avoided.
Performance remained reliable: over the five-year rollout, quality acceptance rates averaged 99.5% and supply shortages registered at zero, thanks to Berry’s vertically integrated capability and diversified global footprint. While costs initially rose (+15% at 25% rPCR and ~+20% at 100% rPCR), scale and contracting helped tame price volatility. Consumer research showed that 58% were willing to pay a premium for 100% recycled packaging, and Dove’s brand favorability rose by 18 points over the period.
Addressing the controversy: Not all rPCR is equal
There is a legitimate debate around rPCR quality, and it is vital to separate material capability from process execution (CONT-BERRY-001). Concerns include residual contamination, color and clarity shifts, mechanical strength variance, and batch inconsistency—especially when feedstock is poorly sorted or insufficiently cleaned. The balanced view is straightforward:
- Low-quality rPCR: basic mechanical recycling (grind + simple wash + re-pelletize) can leave 2–5% contaminants, noticeable gray color, occasional odor, and measurable property drops, making it unsuitable for stringent food-contact applications.
- High-quality rPCR via Super Clean: with multi-stage cleaning, high-temperature treatment, vacuum degassing, and FDA LNO oversight, residuals are driven below the 10 ppm threshold; purity exceeds 99.9%; performance differences narrow to <10% versus virgin—adequate for many mainstream packaging uses.
Thus, the controversy is resolved by process quality: when rPCR is engineered with Berry’s Super Clean approach and validated under ASTM and FDA standards, it is safe and fit for purpose in numerous food, personal care, and non-direct-contact medical packaging applications. By contrast, low-grade rPCR should be limited to non-food or industrial contexts where risks are acceptable.
From testing to design: Practical guidelines for engineering teams
To successfully integrate rPCR while maintaining performance, engineering teams can adopt several proven strategies drawn from Berry Global’s programs:
- Specify quality tiers: Require Super Clean rPCR with documented FDA LNO and batch COAs. Align feedstock types (e.g., PCR PET bottle flake vs. mixed streams) with end-use demands.
- Use multilayer designs: For HDPE and PP containers, coextruded structures can blend aesthetics, barrier, and mechanical performance while maximizing rPCR content.
- Tune blends: Start at 25–50% rPCR for sensitive applications, qualify to 75–100% when test data confirms stability. Reference ASTM D2463 and F1927 results to set acceptance bands.
- Optimize geometry: Reinforce critical areas (base, shoulder) to offset slight mechanical deltas observed with rPCR, preserving drop and top-load performance.
- Plan for color management: Anticipate a neutral-to-gray hue; leverage label design and on-pack claims to turn “eco” aesthetics into brand equity.
- Institutionalize QA: Implement batch-to-batch migration testing, OTR checks, and traceability to feedstock origin. Reject nonconforming lots proactively.
Policy, markets, and circular economy: Why momentum will continue
Regulation and market dynamics now reinforce rPCR adoption (RESEARCH-BERRY-001). The EU’s PPWR framework compels rising rPCR content—e.g., ≥25% rPET in beverage bottles by 2025 and ~30% rPCR across plastic packaging by 2030—with penalties for noncompliance. U.S. states such as California (SB 54) and New York are advancing similar requirements. Globally, the rPCR market reached roughly $15B in 2024 and is growing at ~18% CAGR through 2029, with rPET leading share due to bottle-to-bottle demand and established collection systems.
Prices currently carry premiums (e.g., rPET at $1,500/ton vs. virgin PET at ~$1,100/ton), driven by demand outpacing supply, higher collection/cleaning costs, and policy pressure. However, scale effects, long-term contracts, and technology (including chemical recycling for difficult-to-recycle streams) are narrowing the gap. Berry Global’s investment partnerships—such as advancing chemical recycling capacity—are intended to stabilize supply and push toward cost parity by the end of the decade.
Berry Global’s advantage: Full portfolio and vertical integration
What distinguishes Berry Global is the combination of breadth and depth:
- Full portfolio coverage: rigid containers (food cans, pharma and personal care bottles), flexible packaging films (shrink, stretch, agricultural), nonwovens (medical PPE, hygiene), and closures (caps, pumps, sprayers).
- Vertical integration: upstream resin strategies (PE/PP/PET), midstream processing (blow, injection, extrusion), downstream decoration/printing/assembly—offering speed, cost control, and quality assurance.
- Healthcare + industrial dual engine: medical packaging and PPE alongside industrial and consumer packaging, enabling resilient demand and diversified expertise.
- Impact commitments: products designed for reuse, recycling, or compostability by 2025; Scope 1+2 carbon neutrality by 2030; ≥30% recycled content across portfolios by 2030 with measurable progress (e.g., 25% rPET/rPE usage in 2023).
This integrated capability is what allowed Berry to execute extraordinary supply-chain agility during the COVID-19 pandemic—expanding U.S. medical nonwoven gown production ~100x in ~100 days, investing ~$135M, and shipping ~1.5B gowns with zero stockouts—then flexing capacity post-crisis to sustain healthcare readiness while serving consumer and industrial markets. The same playbook underpins rPCR scale-ups: rapid qualification, multi-site manufacturing, and consistent global supply.
Bottom line: Evidence over assumptions
The rPCR-versus-virgin debate should be decided by data and process. ASTM results demonstrate that high-quality, Super Clean rPCR blends can meet bottle performance targets with differences typically under 10% and remain safely inside FDA migration limits. Commercialization at global scale confirms reliability: Unilever’s Dove moved from 25% rPCR to 100% rPCR across ~80% of markets, cumulative rPCR usage of 120,000 tons, zero supply disruptions, and strong consumer response.
The caveat is essential: not all rPCR is created equal. Inferior processes drive contamination and property deficits that are unacceptable in food-contact applications. Berry Global’s approach—combining rigorous Super Clean decontamination, ASTM/FDA validation, multilayer design, and vertically integrated manufacturing—sets a repeatable standard for brands aiming to cut carbon, comply with rising policy mandates, and build consumer trust without compromising package performance.
For engineers and sustainability leaders, the path forward is clear: specify Super Clean rPCR, qualify with ASTM protocols, design thoughtfully, and partner with suppliers that can prove performance and scale. The result is packaging that delivers on both metrics—performance and circularity.